Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Lung cancer is the leading cause of cancer deaths worldwide, mainly because it gets detected late. The discovery by the ...

After successfully overcoming prostate cancer back in 2019, Jess Magee's father, Peter, was diagnosed with stage 4 lung cancer last year, caused by an EGFR gene mutation. This diagnosis, especially ...

Breast 16: 104–107 The recent discovery that the different types of breast carcinoma have distinctive gene expression signatures ... therapies targeted against EGFR. The authors found that ...

Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR.

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.